NEIL STAHL

Insider Reports History

Location
Tarrytown, NY
Signature
/s/ Neil E. Stahl
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by NEIL STAHL:

Company Role Class Num Shares Value Price $ Report Date Ownership
REGENERON PHARMACEUTICALS, INC. EVP Research and Development Common Stock 48,829 $35,684,721 $730.81 16 Dec 2024 Direct
REGENERON PHARMACEUTICALS, INC. EVP Research and Development Common Stock 5,849 $4,274,508 $730.81 16 Dec 2024 By 401(k) Plan
REGENERON PHARMACEUTICALS, INC. EVP Research and Development Common Stock 4,605 $3,365,380 $730.81 16 Dec 2024 by Spouse as Trustee
REGENERON PHARMACEUTICALS, INC. EVP Research and Development Non-Qualified Stock Option (right to buy) 45,000 02 Aug 2024 Direct
REGENERON PHARMACEUTICALS, INC. EVP Research and Development Non-Qualified Stock Option (right to buy) 0 02 Feb 2024 Direct

Insider Reports Filed by NEIL STAHL

Symbol Company Period Transactions Value $ Form Type Role Filing Time
REGN REGENERON PHARMACEUTICALS, INC. 16 Dec 2024 1 -$222,166 4 EVP Research and Development 18 Dec 2024, 16:02
REGN REGENERON PHARMACEUTICALS, INC. 09 Dec 2024 1 -$366,742 4 EVP Research and Development 10 Dec 2024, 16:03
REGN REGENERON PHARMACEUTICALS, INC. 13 Aug 2024 1 $0 4 EVP Research and Development 14 Aug 2024, 16:01
REGN REGENERON PHARMACEUTICALS, INC. 08 Aug 2024 7 -$5,636,346 4 EVP Research and Development 12 Aug 2024, 16:05
REGN REGENERON PHARMACEUTICALS, INC. 02 Aug 2024 3 -$7,030,122 4 EVP Research and Development 06 Aug 2024, 16:03
REGN REGENERON PHARMACEUTICALS, INC. 26 Feb 2024 1 $0 4 EVP Research and Development 28 Feb 2024, 16:04
REGN REGENERON PHARMACEUTICALS, INC. 07 Feb 2024 7 -$7,637,954 4 EVP Research and Development 08 Feb 2024, 16:02
REGN REGENERON PHARMACEUTICALS, INC. 02 Feb 2024 3 -$9,438,846 4 EVP Research and Development 06 Feb 2024, 16:08
REGN REGENERON PHARMACEUTICALS, INC. 08 Dec 2023 4 -$1,294,591 4 EVP Research and Development 12 Dec 2023, 16:05
REGN REGENERON PHARMACEUTICALS, INC. 10 Nov 2023 1 $0 4 EVP Research and Development 14 Nov 2023, 16:03
REGN REGENERON PHARMACEUTICALS, INC. 21 Aug 2023 6 -$21,775,088 4 EVP Research and Development 23 Aug 2023, 17:03
REGN REGENERON PHARMACEUTICALS, INC. 16 Dec 2022 2 $0 4 EVP Research and Development 20 Dec 2022, 15:08
REGN REGENERON PHARMACEUTICALS, INC. 09 Dec 2022 2 -$351,028 4 EVP Research and Development 13 Dec 2022, 15:11
REGN REGENERON PHARMACEUTICALS, INC. 04 Aug 2022 20 -$32,534,918 4 EVP Research and Development 08 Aug 2022, 16:11
REGN REGENERON PHARMACEUTICALS, INC. 11 Dec 2021 1 -$500,248 4 EVP Research and Development 14 Dec 2021, 15:08
REGN REGENERON PHARMACEUTICALS, INC. 08 Dec 2021 2 $0 4 EVP Research and Development 10 Dec 2021, 16:35
REGN REGENERON PHARMACEUTICALS, INC. 03 Dec 2021 5 -$18,858,197 4 EVP Research and Development 06 Dec 2021, 15:10
REGN REGENERON PHARMACEUTICALS, INC. 14 May 2021 10 -$19,359,184 4 EVP Research and Development 18 May 2021, 16:04